Logo-npj
Submitted: 20 Aug 2018
Accepted: 17 Oct 2018
ePublished: 03 Dec 2018
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2019;8(1): e04.
doi: 10.15171/npj.2019.04

Scopus ID: 85079441190
  Abstract View: 11339
  PDF Download: 5151

Original

Multistate Markov model for predicting the natural disease progression of type 2 diabetes based on hemoglobin A1c

Komal Goel 1*, Gurprit Grover 2, Ankita Sharma 1, Sejong Bae 3

1 Department of Statistics and, Faculty of Mathematical Sciences, University of Delhi, India
2 Department of Statistics, Faculty of Mathematical Sciences, University of Delhi, India
3 Division of Preventive Medicine, University Alabama School of Medicine, Alabama, USA
*Corresponding Author: *Corresponding author: Komal Goel, Email: komalstats@gmail.com, Email: komalstats@gmail.com

Abstract

Introduction: Type 2 diabetes is a common non-communicable disease, especially in developing countries like India, posing a huge economic burden on the family and nation as a whole. It is a chronic metabolic disorder in which prevalence has been increasing steadily all over the world. In studies of many chronic medical conditions, the health status of a patient may be characterized using a finite number of disease states. The multi-state Markov model is a useful way to describe states of a disease over time. In this research article, we have illustrated the usefulness of multistate Markov models in the analysis of follow-up of diabetes. The valuable information provided by the hemoglobin A1c (HbA1c) test has rendered it as a reliable biomarker for the diagnosis and prognosis of diabetes.

Objectives: The main purpose of this study is to assess the importance and significance of HbA1c as a useful disease marker for type 2 diabetes by using a three-state Markov model.

Patients and Methods: A total of 246 type 2 diabetic patients were included in this study. These patients are classified in different states on the basis of their available baseline value of HbA1c. HbA1c repeated after every 1 year for consecutive four years. Based on ranges of HbA1c, three transient states (4 ≤ HbA1C ≤ 5.6, 5.7 ≤ HbA1C ≤ 6.4 and HbA1C ≥ 6.5%) have been defined. Additionally, transition intensities, transition probabilities, mean sojourn time in each state and also expected state specific survival time have been assessed. All the statistical analysis has been performed using the msm package in R software.

Results: The mean age of patients at diagnosis was 26.12 years (SD=7.60), ranging from 10 to 49 years. The estimates of transition intensities reveal that a patient in state 1 is 16.4 (0.82/0.05) times more likely to move to state 2 than to move to diabetic state. Similarly, a patient in pre-diabetic is 7.5 (2.34/0.31) times more likely to move to diabetic state as compared to normal state. Additionally, once a patient is in a diabetic state there is 79% chances of remaining in a diabetic state as compared to 4% and 17% of moving to normal or pre-diabetic state, this implies that a patient who once in the diabetic state is difficult to move to a normal or pre-diabetic state.

Conclusion: The estimated total length of time spent in each state is forecasted to be four months in normal state, five months in pre-diabetic state and 39 months in diabetic state. Hence, it has been concluded that, once the patient enters the diabetic state (HbA1c>6.4), the chances of getting back to normal or pre-diabetic state are very small.


Implication for health policy/practice/research/medical education:

Once the patient enters the diabetic state (HbA1c>6.4%), the chances of getting back to normal or pre-diabetic state are very small.

Please cite this paper as: Goel K, Grover G, Sharma A, Bae S. Multistate Markov model for predicting the natural disease progression of type 2 diabetes based on hemoglobin A1c. J Nephropharmacol. 2019;8(1):e04. DOI: 10.15171/npj.2019.04

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 11340

Your browser does not support the canvas element.


PDF Download: 5151

Your browser does not support the canvas element.